Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Helminth | 1 | 2025 | 4 | 0.910 |
Why?
|
| Genome | 2 | 2023 | 149 | 0.900 |
Why?
|
| Rotifera | 1 | 2025 | 13 | 0.890 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2024 | 2 | 0.840 |
Why?
|
| Chromosomes | 1 | 2023 | 43 | 0.810 |
Why?
|
| Mucin-1 | 1 | 2021 | 12 | 0.690 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2026 | 31 | 0.670 |
Why?
|
| Cyperaceae | 1 | 2020 | 2 | 0.650 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2020 | 65 | 0.630 |
Why?
|
| Escherichia coli | 3 | 2026 | 460 | 0.550 |
Why?
|
| Ducks | 3 | 2023 | 30 | 0.540 |
Why?
|
| Ribosome Subunits, Large, Bacterial | 3 | 2026 | 3 | 0.530 |
Why?
|
| Glycosylation | 2 | 2024 | 113 | 0.370 |
Why?
|
| Protein Isoforms | 2 | 2024 | 139 | 0.370 |
Why?
|
| RNA, Bacterial | 3 | 2026 | 40 | 0.350 |
Why?
|
| Escherichia coli Proteins | 3 | 2026 | 133 | 0.300 |
Why?
|
| RNA, Ribosomal | 2 | 2026 | 31 | 0.300 |
Why?
|
| North America | 2 | 2023 | 85 | 0.240 |
Why?
|
| Genomics | 3 | 2023 | 293 | 0.240 |
Why?
|
| Arthritis, Experimental | 1 | 2025 | 8 | 0.230 |
Why?
|
| Thyroid Neoplasms | 1 | 2026 | 50 | 0.230 |
Why?
|
| Neuropeptide Y | 1 | 2025 | 25 | 0.230 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2025 | 36 | 0.230 |
Why?
|
| Sirolimus | 1 | 2025 | 70 | 0.220 |
Why?
|
| Body Size | 1 | 2025 | 49 | 0.220 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2025 | 58 | 0.220 |
Why?
|
| Chromatiaceae | 1 | 2024 | 1 | 0.220 |
Why?
|
| Autotrophic Processes | 1 | 2024 | 2 | 0.220 |
Why?
|
| Stress, Physiological | 1 | 2026 | 172 | 0.220 |
Why?
|
| Sulfur | 1 | 2024 | 22 | 0.220 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 93 | 0.210 |
Why?
|
| Sulfides | 1 | 2024 | 78 | 0.200 |
Why?
|
| Humans | 15 | 2026 | 43102 | 0.200 |
Why?
|
| Leukemia | 1 | 2023 | 54 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2023 | 91 | 0.190 |
Why?
|
| Iron | 1 | 2024 | 251 | 0.190 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.180 |
Why?
|
| Ovarian Neoplasms | 1 | 2026 | 415 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2026 | 863 | 0.170 |
Why?
|
| Pyrazoles | 1 | 2022 | 103 | 0.170 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 41 | 0.170 |
Why?
|
| Phylogeny | 1 | 2025 | 769 | 0.170 |
Why?
|
| Receptors, CCR5 | 2 | 2018 | 64 | 0.170 |
Why?
|
| Sequence Analysis, Protein | 1 | 2020 | 52 | 0.170 |
Why?
|
| Extreme Heat | 1 | 2020 | 4 | 0.160 |
Why?
|
| Arctic Regions | 1 | 2020 | 21 | 0.160 |
Why?
|
| Peptides | 1 | 2024 | 372 | 0.160 |
Why?
|
| Alaska | 1 | 2020 | 62 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 139 | 0.160 |
Why?
|
| HIV-1 | 2 | 2018 | 755 | 0.160 |
Why?
|
| Animals, Wild | 1 | 2020 | 24 | 0.160 |
Why?
|
| Gene Expression Profiling | 2 | 2022 | 704 | 0.160 |
Why?
|
| Inflammation | 1 | 2025 | 758 | 0.150 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 5 | 0.150 |
Why?
|
| Flavivirus | 1 | 2019 | 16 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2025 | 2157 | 0.150 |
Why?
|
| HIV Long-Term Survivors | 1 | 2018 | 7 | 0.150 |
Why?
|
| Temperature | 1 | 2020 | 313 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2018 | 36 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 209 | 0.130 |
Why?
|
| Algorithms | 1 | 2020 | 509 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 333 | 0.130 |
Why?
|
| Virus Replication | 1 | 2019 | 318 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2026 | 1092 | 0.120 |
Why?
|
| RNA, Ribosomal, 23S | 2 | 2026 | 6 | 0.110 |
Why?
|
| Bystander Effect | 1 | 2012 | 15 | 0.100 |
Why?
|
| Hybridization, Genetic | 2 | 2023 | 25 | 0.090 |
Why?
|
| HIV Infections | 2 | 2018 | 2586 | 0.090 |
Why?
|
| Phosphorylation | 2 | 2023 | 986 | 0.080 |
Why?
|
| Autophagy | 2 | 2025 | 140 | 0.070 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2018 | 7 | 0.060 |
Why?
|
| Mice, Inbred DBA | 1 | 2025 | 73 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 1 | 2026 | 115 | 0.060 |
Why?
|
| Apoptosis | 1 | 2012 | 1568 | 0.060 |
Why?
|
| Proportional Hazards Models | 1 | 2026 | 518 | 0.050 |
Why?
|
| Photosynthesis | 1 | 2024 | 35 | 0.050 |
Why?
|
| Pseudouridine | 1 | 2023 | 6 | 0.050 |
Why?
|
| Electrons | 1 | 2024 | 76 | 0.050 |
Why?
|
| Ribosomes | 1 | 2023 | 35 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 25 | 0.050 |
Why?
|
| Breeding | 1 | 2023 | 28 | 0.050 |
Why?
|
| Computational Biology | 1 | 2026 | 327 | 0.050 |
Why?
|
| Europe | 1 | 2023 | 115 | 0.050 |
Why?
|
| Janus Kinase 1 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Janus Kinase 3 | 1 | 2023 | 36 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 23 | 0.050 |
Why?
|
| Prognosis | 1 | 2026 | 861 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 22 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2022 | 155 | 0.050 |
Why?
|
| Exocytosis | 1 | 2022 | 49 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2022 | 90 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 79 | 0.040 |
Why?
|
| Caspases | 1 | 2022 | 148 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2022 | 157 | 0.040 |
Why?
|
| Tubulin | 1 | 2022 | 96 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2022 | 416 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 388 | 0.040 |
Why?
|
| Microtubules | 1 | 2022 | 121 | 0.040 |
Why?
|
| Cell Death | 1 | 2022 | 278 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2022 | 462 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 290 | 0.040 |
Why?
|
| Databases, Protein | 1 | 2020 | 54 | 0.040 |
Why?
|
| Binding Sites | 1 | 2022 | 671 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2022 | 346 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 298 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 277 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 228 | 0.040 |
Why?
|
| Gene Flow | 1 | 2020 | 31 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.040 |
Why?
|
| Male | 3 | 2026 | 23409 | 0.040 |
Why?
|
| RNA Viruses | 1 | 2019 | 22 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2019 | 29 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 257 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 595 | 0.040 |
Why?
|
| Hospitalization | 1 | 2023 | 485 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 186 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 532 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 189 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2019 | 119 | 0.040 |
Why?
|
| Protein Binding | 1 | 2022 | 1082 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2022 | 876 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Cell Movement | 1 | 2022 | 655 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 695 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 201 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 515 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 1177 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 701 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 968 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1455 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 1410 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2676 | 0.030 |
Why?
|
| Mice | 1 | 2025 | 6644 | 0.030 |
Why?
|
| Female | 2 | 2026 | 24698 | 0.030 |
Why?
|
| Aged | 1 | 2026 | 8214 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2012 | 11 | 0.020 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 17 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 74 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 12222 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 667 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 1596 | 0.020 |
Why?
|